Today

Agents

Chat

Arena

Discover

More

App

GSK Says Nucala Receives Positive Reimbursement Recommendation From CDA-AMC - GSK News | Rallies

GSK Says Nucala Receives Positive Reimbursement Recommendation From CDA-AMC

GSK•2026-08-18

Positive reimbursement recommendation for Nucala

GSK: Nucala (mepolizumab) receives positive reimbursement recommendation from CDA-AMC for adults with chronic obstructive pulmonary disease

Related News

Nasdaq trade halt continues <UCFIW.O> reason not available at 10:17 AM

UCFIW•2026-08-18

Nasdaq trade halt continues <RCON.O> volatility trading pause at 11:01 AM

RCON•2026-08-18

Nasdaq Trade Halt <IPST.O> Volatility Trading Pause at 10:25 AM

IPST•2026-08-18

D

Diageo publishes 2026 annual report

DEO•2026-08-18

Nasdaq Trade Halt <IPST.O> Volatility Trading Pause at 10:54 AM

IPST•2026-08-18